CALCA and COVID-19: In this context, a biomarker such as PCT, a widely used clinical practice to rapidly detect severe bacterial infections in the period before the pandemic, was thought to play a key role in early diagnosis and the modulation of antibiotic therapy even in the superinfected COVID-19 patients [5,6,7,8,9,10,11,12,13,14,15,16,31].